Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2023-07-05 00:00:00 ET · period of report 2023-06-30 · accession 0001209191-23-041175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-05 | 2023-06-30 | ALXO | GARCIA PETER S | CFO | S - Sale | $7.34 | -887 | 54.7K | -2% | -$6,511 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | S | D | 887 | $7.34 | 54,738 | D | — | — | (F2) Includes 1,902 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023. |